Last reviewed · How we verify
EX039
EX039's mechanism of action is currently under investigation and not fully characterized.
At a glance
| Generic name | EX039 |
|---|---|
| Sponsor | Excelsior |
| Modality | Small molecule |
| Phase | Phase 2 |
Mechanism of action
As a drug in Phase 2 trials, EX039's specific biological interactions and pathways are still being studied to determine its precise mode of action.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |